Gupta, V., Kennedy, J. A., Capo-Chichi, J., Kim, S., Hu, Z., Alyea, E. P., . . . Saber, W. (2020). Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv.
Chicago ZitierstilGupta, Vikas, et al. "Genetic Factors Rather Than Blast Reduction Determine Outcomes of Allogeneic HCT in BCR-ABL–negative MPN in Blast Phase." Blood Adv 2020.
MLA ZitierstilGupta, Vikas, et al. "Genetic Factors Rather Than Blast Reduction Determine Outcomes of Allogeneic HCT in BCR-ABL–negative MPN in Blast Phase." Blood Adv 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.